Centers for Disease Control and Prevention

Codagenix scores again: $3M to hunt down deadly RSV

By GREGORY ZELLER // A fresh $3 million in public and private investments has set Codagenix Inc. on the trail of another nefarious disease. Already developing vaccines for Zika virus, the mutating menace Influenza A and a host of other viral villains, Codagenix will now focus its vaccine-creation might on Respiratory Syncytial Virus through a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health and another $1.5 million in…


Knapp gift locks Feinstein bioelectronics on diabetes

By GREGORY ZELLER // A new research program will focus the Feinstein Institute for Medical Research’s considerable bioelectronic resources on a main antagonist of American health: diabetes. The research and development division of the Northwell Health system has received a $1 million gift from The Knapp Foundation, enough to kick off a four-year effort to explore bioelectronic medicine-based treatments for the chronic disease, which affects more than 29 million Americans – just under 10 percent…


With help, Adelphi researchers target common STD

Two Adelphi University professors exploring a common sexually transmitted disease have earned a healthy federal grant. The National Institutes of Health has awarded associate professors Brian Stockman and Melissa VanAlstine-Parris, both PhDs and members of the university’s Chemistry Department, a $310,934 grant to further their research into trichomoniasis, the most prevalent non-viral STD. The grant is designed to involve undergraduate students in the professors’ cutting-edge research, including hands-on use of nuclear magnetic resonance spectroscopy, medicinal…